Core Laboratories (CLB) Tops Q2 EPS by 1c, Revenues Miss; Q3 EPS Mid-Point Guidance Below Consensus, Q3 Rev. Outlook Below Consensus

July 24, 2019 5:43 PM

Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.46, $0.01 better than the analyst estimate of $0.45. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found